European Food Safety Authority issues positive opinion on ChromaDex’s Nicotinamide Riboside as a novel food
ChromaDex is one step closer to regulatory approval in the European Union with this positive opinion from the European Food Safety Authority.
Photo © Shutterstock.com/AlexLMX
ChromaDex Corp. announced that the European Food Safety Authority (EFSA) issued a positive opinion on nicotinamide riboside (NR) as a novel food ingredient for use in food supplements, at a serving of 300 mg daily, for the healthy adult population. Now NR will advance to the European Commission for review. Once the regulatory process for the European market is complete, ChromaDex plans to launch its flagship NR product Tru Niagen in the European Union (EU).
“Safety is paramount for ChromaDex and this positive opinion from EFSA underscores our depth of science, and is the latest in a consistently positive series of reviews of NR by authoritative bodies,” said ChromaDex CEO Rob Fried, in a press release. “We are diligently working to complete the regulatory process to bring NR to the health-conscious people of the EU.”
Senate Committee has released the text of 2024 Farm Bill, with changes to hemp regulations
November 19th 2024The U.S. Senate Committee on Agriculture, Nutrition, & Forestry has introduced the Rural Prosperity and Food Security Act, which will serve as the Senate’s draft for the 2024 Farm Bill.
NPA’s lawsuit against FDA on NMN stayed pending agency’s decision on citizen petition
November 6th 2024The court has granted a joint motion for stay filed by NPA and FDA, pending the agency's decision on the citizen petition asking FDA to reverse its stance on NMN's status as a dietary ingredient.
